AGNPF (Grey Matters Health) EBIT: $-1.49 Mil (TTM As of Feb. 2026)


AGNPF Grey Matters Health Inc AGNPF
26 GF Score
Price $0.26
! 1 Warning Sign
View Full Analysis

What is Grey Matters Health EBIT?

Grey Matters Health AGNPF -3.43% 26 EBIT is $-1.49 Mil as of Feb. 2026. GuruFocus rates AGNPF with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Grey Matters Health's earnings before interest and taxes (EBIT) for the three months ended in Feb. 2026 was $-0.37 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2026 was $-1.49 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Grey Matters Health's annualized ROC % for the quarter that ended in Feb. 2026 was -46.97%. Grey Matters Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Grey Matters Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was -92.82%.

Grey Matters Health  (OTCPK:AGNPF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Grey Matters Health's annualized ROC % for the quarter that ended in Feb. 2026 is calculated as:

ROC % (Q: Feb. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2025 ) + Invested Capital (Q: Feb. 2026 ))/ count )
=-1.464 * ( 1 - 0% )/( (3.07 + 3.164)/ 2 )
=-1.464/3.117
=-46.97 %

where

Invested Capital(Q: Nov. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.507 - 1.738 - ( 0.149 - max(0, 1.738 - 0.437+0.149))
=3.07

Invested Capital(Q: Feb. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.626 - 1.827 - ( 0.143 - max(0, 1.827 - 0.462+0.143))
=3.164

Note: The Operating Income data used here is four times the quarterly (Feb. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Grey Matters Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2025  Q: Feb. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1.464/( ( (0 + max(-1.45, 0)) + (0 + max(-1.508, 0)) )/ 2 )
=-1.464/( ( 0 + 0 )/ 2 )
=-1.464/0
= %

where Working Capital is:

Working Capital(Q: Nov. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.011 + 0 + 0.277) - (1.738 + 0 + 0)
=-1.45

Working Capital(Q: Feb. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.02 + 0 + 0.299) - (1.827 + 0 + 0)
=-1.508

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Grey Matters Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2026 )
=-1.487/1.602
=-92.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Matters Health EBIT Related Terms

Grey Matters Health EBIT Historical Data

* Premium members only.

The historical data trend for Grey Matters Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Matters Health EBIT Chart

Grey Matters Health Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.39 -4.66 -3.89 -1.77 -1.25

Grey Matters Health Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.26 -0.42 -0.28 -0.43 -0.37

AGNPF vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, Grey Matters Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grey Matters Health EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Grey Matters Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Grey Matters Health's EV-to-EBIT falls into.


AGNPF
26GF Score
Grey Matters Health Inc AGNPF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Matters Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-1.49 Mil mean?
Grey Matters Health (AGNPF) has a EBIT of $-1.49 Mil as of Feb. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Grey Matters Health.
Is Grey Matters Health's EBIT too high?
Grey Matters Health's current EBIT is $-1.49 Mil. Overall, Grey Matters Health has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Grey Matters Health's EBIT compare to VRTX and REGN?
Grey Matters Health's EBIT of $-1.49 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Grey Matters Health. Grey Matters Health's current EBIT is $-1.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Matters Health stock overvalued right now?
Grey Matters Health (AGNPF) has a current EBIT of $-1.49 Mil. The current EBIT is $-1.49 Mil. Grey Matters Health's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Grey Matters Health (AGNPF), the current EBIT is $-1.49 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grey Matters Health Business Description

Other Exchanges GREY:Canada
Address 601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2
Grey Matters Health Inc is a drug repurposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations, and seeking new regulatory approvals in world-wide markets.
26GF Score

Get the complete analysis for AGNPF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price